Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid
Part of paid clinical trials in Charlottesville, Virginia.
- Sponsor
- University of Virginia
- Study ID
- NCT07694492
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Nicotine Dependence
- Smokeless Tobacco Use
- Tobacco Use Cessation
- Tobacco Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- QuitAid (pharmacist-delivered MTM) — BEHAVIORALSix telephonic pharmacist coaching sessions over 4 weeks focused on setting a quit date and quitting TNPs. The first session (and subsequent proactive calls at \~days 2, 7, 14, 21, and 28) addresses negative beliefs about NRT, strengthens motivation and commitment to NRT use, monitors NRT use, provides feedback, and supports adherence. Includes the Pre-Quit Motivation Modules (up to three telephonic sessions) for participants not yet ready to quit.
- Nicotine Replacement Therapy (NRT) — DRUG24 weeks of NRT dispensed under a standing order and mailed to participants, with standard use guidelines. Product is matched to TNP type: long-acting patch for smoked TNP users, short-acting gum for oral TNP users, patch for dual users.
Study Details
Coal miners in Central Appalachia have among the highest rates of tobacco and nicotine product (TNP) use of any occupational group and face elevated rates of lung cancer and coal workers' pneumoconiosis ("black lung"). This study tests a novel medical-legal partnership (MLP) that "flips" the traditional referral direction: lawyers representing coal miners in black-lung workers' compensation cases identify clients who use TNPs and, through an ask-advise-connect process, connect them to community pharmacists who deliver QuitAid, a pharmacist-delivered medication therapy management (MTM) program, together with nicotine replacement therapy (NRT). The study has two aims: (1) an implementation-science evaluation of the ask-advise-connect process in black-lung law offices, and (2) a randomized feasibility pilot in which coal miners who use TNPs are randomized to receive QuitAid or not, with all participants receiving 24 weeks of NRT. As a feasibility pilot, the study is designed to estimate recruitment, randomization, retention, fidelity, and dose parameters to inform a future NCI R01, and is not powered to detect differences between conditions.
Key Dates
- First listed
- Jul 10, 2026
- Start date
- Sep 1, 2026
- Status verified
- Jul 2026
- Primary completion
- Sep 30, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: QuitAid + NRTParticipants receive the pharmacist-delivered QuitAid MTM program plus 24 weeks of NRT. Those ready to quit receive six telephonic coaching sessions over 4 weeks; those not ready to quit receive up to three Pre-Quit Motivation Modules and may transition to QuitAid upon reporting readiness at a weekly check-in (Weeks 1-4).
- Active Comparator: NRT OnlyParticipants receive 24 weeks of NRT beginning in Week 1 without the QuitAid MTM program. All follow-up assessments are conducted regardless of condition.
Primary Outcome Measure
Feasibility of Randomization [ Time Frame: Through study recruitment (approximately 6 months) ]
Central Contacts
- Ashley N DeMoss, MPH(304) 574-8073
- Dylan Allanson, MPH, RD4342430424
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Virginia | Charlottesville | Virginia | 22903 | Melissa A Little, PhD, MPH (PRINCIPAL_INVESTIGATOR) Drew Harris, MD (PRINCIPAL_INVESTIGATOR) Candace H Wood, PharmD (SUB_INVESTIGATOR) Roger T Anderson, PhD (SUB_INVESTIGATOR) |
Find similar trials in Charlottesville, VA
Related Studies
- Comprehensive Tobacco Cessation for Cancer Patients and SurvivorsRecruiting · Virginia Commonwealth University · Richmond, Virginia
- VergeRx for Smokers Not Ready to QuitNot Yet Recruiting · University of Virginia · Charlottesville, Virginia
- Advanced Functional and Structural MRI Techniques for Neuropharmacological ImagingRecruiting · National Institute on Drug Abuse (NIDA) · Baltimore, Maryland
- An fMRI Study of the Effects of Clavulanic Acid on Drug AddictionPHASE2 · Recruiting · University of Missouri-Columbia · Columbia, Missouri